This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
Shanghai Shen Lian Biomedical Corporation (Stock Code: 688098) is a leading high-tech enterprise in veterinary biological products, dedicated to research, development, and production of vaccines and diagnostics for livestock health.
GMP Certified
Shanghai & Lanzhou Facilities
Shanghai Shen Lian Biomedical Corporation, established in June 2001 with a registered capital of 410.64 million RMB, is a high-tech enterprise specializing in the research, development, production, and sales of veterinary biological products. Headquartered in Shanghai, we are committed to safeguarding livestock health and food safety.
In October 2019, we became the first animal health company to list on the Shanghai Stock Exchange's STAR Market (Stock Code: 688098). As a designated enterprise for foot-and-mouth disease (FMD) vaccines by the Chinese Ministry of Agriculture and Rural Affairs, we play a critical role in national disease prevention.
Established
Financial Strength
Doses Delivered
Vaccine Products
We offer a comprehensive portfolio of veterinary vaccines and diagnostic detection kits, developed with cutting-edge biotechnology and manufactured under strict GMP standards.
Inactivated FMDV Strain Re-O/MYA98/JSCZ/2013 and Re-A/WH/09. Total 146S content ≥ 3.0μg/dose.
More Details →
Contains synthetic peptides 2600, 2700, 2800 ≥ 25μg/ml each. Highly specific and safe.
More Details →
Inactivated AV41 strain of Goatpox virus. Virus titer before inactivation: 10⁶.² TCID₅₀/ml.
More Details →
Porcine Circovirus Type 2 Cap recombinant protein. Antigen content ≥ 16.0μg/ml.
More Details →
Inactivated O/MYA98/BY/2010 and A/Re-A/WH/09 strains. Total 146S ≥ 1.0μg/ml.
More Details →Rapid, accurate detection of foot-and-mouth disease virus in livestock.
More Details →High-sensitivity reagents for early detection and control of ASF outbreaks.
More Details →Combined synthetic peptides for Type O and Type A FMDV. Each ≥ 25μg/ml.
More Details →Our commitment to innovation and quality ensures safe, effective, and reliable veterinary solutions trusted by partners worldwide.
Over $67 million invested in research and development. Our team focuses on next-generation vaccines and diagnostics for emerging animal diseases.
Dual GMP production facilities in Shanghai and Lanzhou. BSL-3, GCP, and CNAS certified for highest safety and quality standards.
Strategic partnerships with international veterinary associations, including the African Veterinary Association, to strengthen global livestock health.
Shen Lian Biomedical welcomed Dr. Mohamed Faouzi Kechrid, President of the African Veterinary Association, to strengthen China-Africa cooperation in livestock health and disease prevention.
Read More →The Lanzhou Branch successfully passed the veterinary drug GMP audit and received both the Veterinary Drug GMP Certificate and Production License.
Read More →For inquiries about our products, partnerships, or investor relations, please visit our official website.
Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact [email protected]
如果您是其他域名合作 也请联系[email protected]